Advanced search
Publication Cover
Expert Review of Hematology Volume 14, 2021 - Issue 12: Multiple Myeloma
Submit an article Journal homepage
275
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The development of a home-based therapeutic platform for multiple myeloma

Hayley Beera Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, AustraliaCorrespondence[email protected]
,
David Routledgea Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia;b Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Australia
,
Trish Joycea Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
,
Emma-Jane Furphya Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
,
Nella Combea Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
,
David Ritchiea Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia;b Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Australia
,
Amit Khota Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia;b Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Australia
,
Seok Ming Lima Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
,
Michael Montaltoc Epworth Hospital in the Home Unit, Richmond, Australia
&
Simon J Harrisona Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia;b Sir Peter MacCallum Department of Oncology, Melbourne University, Parkville, Australia
 show all
Pages 1129-1135 | Received 12 Oct 2021, Accepted 21 Dec 2021, Published online: 07 Jan 2022

References

  • Siegel RL, Miller KD, Jernal A. Cancer statistics 2020. CA Cancer J Clin. 2020;70(1):7–30.
  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–54.
  • Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21.
  • Cowen AJ, Allen C, Barac A, et al. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol. 2018;4(9):1221–1227.
  • Cancer.nsw.gov.au. Cancer costs; 2021. [cited 2021 Oct 4]. Available from: https://www.cancer.nsw.gov.au/general-cancer-information/cancer-support/finding-support/cancer-costs
  • Aihw.gov.au. Cancer in Australia; 2019. [cited 2021 Oct 4]. Available from: https://www.aihw.gov.au/getmedia/f4f2b22f-8189-4c51-9e2a-66384cbca683/aihw-can-126.pdf.aspx?inline=true
  • Palumbo A, Gay F, Cavallo F, et al. Continuous therapy versus fixed duration of therapy in patients with newly diagnosed multiple myeloma. J Clin Oncol. 2015;33(30):3459–3466.
  • Avet-Loiseau H. Ultra high-risk myeloma. Hematology Am Soc Hematol Educ Program. 2010;2010:489–493.
  • Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from the international myeloma working group. J Clin Oncol. 2015;33(26):2863–2869.
  • Hulin C, Hansen T, Heron L, et al. Living with the burden of relapse in multiple myeloma from the patient and physician perspective. Leuk Res. 2017;59:75–84.
  • Shepperd S, Doll H, Angus RM, et al. Avoiding hospital admission through provision of hospital care at home: a systematic review and meta-analysis of individual patient data. CMAJ. 2009;180(2):175–182.
  • Smith AG, Soutar RL, Schey S, et al. Home care versus hospital care in patients with multiple myeloma treated with pamidronate. Int J Palliat Nurs. 2004;10(3):144–149. 9.
  • Bergin K, Wellard C, Moore E, et al. The myeloma landscape in Australia and New Zealand: the first 8 years of the Myeloma and Related Diseases Registry (MRDR). Clin Lymphoma, Myeloma, Leukaemia. 2021;21(6):E510–E520.
  • Catania C, De Pas T, Michella I, et al., Waiting and the waiting room: how do you experience them?” Emotional implications and suggestions from patients with cancer. J Cancer Educ. 2011;26(2):388–394.
  • Moreau P, Mateos MV, Berenson JR, et al. Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study. Lancet Oncol. 2018;19(7):953–964.
  • Durie BGM, Hoering A, Sexton R, et al. Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT). Blood Cancer J. 2020;10(5):53.
  • Hu B, Zhou Q, Hu YY, et al. Efficacy and safety of once-weekly versus twice-weekly bortezomib in patients with hematologic malignancies: a meta-analysis with trial sequential analysis. Pharmacotherapy. 2019;39(6):697–708.
  • Raibagkar PS, Richardson PG, Sonneveld P, et al. Hematologica testing is not required with every dose of bortezomib in patients with adequate blood counts at the start of each cycle. Blood. 2010;116:Abstract 1963.
  • Nishimura KK, Barlogie B, van Rhee F, et al. Long-term outcomes after autologous stem cell transplantation for multiple myeloma. Blood Adv. 2020;4(2):422–431.
  • Palumbo A, Cavallo F, Gay F, et al. Autologous transplantation and maintenance therapy in multiple myeloma. N Engl J Med. 2014;371(10):895–905.
  • Kodad SG, Sutherland H, Limvorapitak W, et al. Outpatient autologous stem cell transplants for multiple myeloma: analysis of safety and outcomes in a tertiary care centre. Clin Lymphoma Myeloma Leuk. 2019;19(12):784–790.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.